OCREVUS CONNECTS™: your direct connection to Genentech

The support you need––from product and access questions to help locating infusion centers for patients

  • Answers to product-specific questions from Medical Information Specialists
  • Help finding nearby OCREVUS infusion centers for your patients
  • Patient Navigators to support you and your patients—from access and reimbursement needs to infusion coordination
  • Additional resources (including live programs)

Call 1 (844) OCREVUS (1-844-627-3887)
Monday through Friday, 9 am to 8 pm EST

Download the Patient Navigation Roadmap

This guide provides an overview of the services offered by Genentech and more information about Patient Navigators. Patient Navigators provide support to patients, practices, and infusion sites for access, reimbursement, infusion coordination, and patient assistance options.

6-month dosing schedule

The first dose of OCREVUS is administered as two 300 mg IV infusions 2 weeks apart. Subsequent doses are administered as a single 600 mg infusion every 6 months.

Learn more about IRRs

Learn how to manage infusion-related reactions (IRRs) in your OCREVUS patients.